Neurotrophic and neuroprotective effects of pituitary adenylate cyclase- activating polypeptide (PACAP) on mesencephalic dopaminergic neurons

Journal of Neuroscience Research

Volumn 54, Issue 5, 1998, Pages 698-706

  Takei, Nobuyuki ^a   Skoglösa, Ylva ^a   Lindholm, Dan ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

GDNF; Neuronal culture; Neurotoxicity; PACAP; Tyrosine hydroxylase

Indexed keywords

DOPAMINE; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; NEURITE PROMOTING FACTOR; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL PROTECTION; DOPAMINE UPTAKE; DOPAMINERGIC NERVE CELL; EMBRYO; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; MESENCEPHALON; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; BIOLOGICAL TRANSPORT; CELLS, CULTURED; DOPAMINE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; IN SITU HYBRIDIZATION; MESENCEPHALON; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; NEURONS; NEUROPEPTIDES; NEUROPROTECTIVE AGENTS; OXIDOPAMINE; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RECEPTORS, PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE, TYPE I; RECEPTORS, PITUITARY HORMONE; RNA, MESSENGER; SIGNAL TRANSDUCTION;

EID: 0032401022     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19981201)54:5<698::AID-JNR15>3.0.CO;2-5     Document Type: Article

References (36)

1. Arimura A (1992): Pituitary adenylate cyclase activating polypeptide (PACAP): Discovery and current status of research. Regul Pept 37:287-303.
2. Arimura A, Somogyvari-Vigh A, Miyata A, Mizuno K, Coy DH, Kitada C (1991): Tissue distribution of PACAP as determined by RIA: Highly abundant in the rat brain and testes. Endocrinology 129:2787-2789.
3. Banks WA, Kastin AJ, Komaki G, Arimura A (1993): Passage of pituitary adenylate cyclase activating polypeptide 1-27 and pituitary adenylate cyclase activating polypeptide 1-38 across the blood-brain barrier. J Pharmacol Exp Ther 267:690-696
4. Brenneman DE, Foster G (1987): Structural specificity of peptides influencing neuronal survival during development. Peptides 8:687-694.
5. Deutsch PJ, Sun Y (1992): The 38-amino acid form of pituitary adenylate cyclase-activating polypeptide stimulates dual signaling cascades in PC12 cells and promotes neurite outgrowth. J Biol Chem 267:5108-5113.
6. Gottschall PE, Tatsuno I, Arimura A (1994): Regulation of interleukin-6 (IL-6) secretion in primary cultured rat astrocytes: Synergism of interleukin-1 (IL-1) and pituitary adenylate cyclase activating polypeptide (PACAP). Brain Res 637:197-203.
7. Hama T, Kushima Y, Miyamoto M, Kubota M, Takei N, Hatanaka H (1991): Interleukin-6 improves the survival of mecencephalic catecholaminergic and septal cholinergic neurons from postnatal, two-week-old rats in cultures. Neuroscience 40:445-452.
8. Hashimoto H, Nogi H, Mori K, Ohishi H, Sigemoto R, Yamamoto K, Matsuda T, Mizuno N, Nagata S, Baba A (1996): Distribution of the mRNA for a pituitary adenylate cyclase-activating polypeptide receptor in the rat brain: An in situ hybridization study. J Comp Neurol 371:567-577.
9. Hatanaka H, Arimatsu Y (1984): Monoclonal antibodies to tyrosine hydroxylase from rat pheochromocytoma PC12h cells with special reference to nerve growth factor-mediated increase of the immunoprecipitable enzymes. Neurosci Res 1:253-263.
10. Hou JGG, Lin L-FH, Mytilineou C (1996): Glial cell line-derived neurotrophic factor exerts neurotrophic effects on dopaminergic neurons in vitro and promotes their survival and regrowth after damage by 1-methyl-4-phenylpyridinium. J Neurochem 66: 74-82.
11. Hyman C, Hofer M, Barde Y-A, Juhasz M, Yancopoulos G, Squinto SP, Lindsay RM (1991): BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra. Nature 350:230-232.
12. Knusel B, Winslow, JW, Rosenthal A, Burton LE, Seid DP, Nikolics K, Hefti F (1991): Promotion of central cholinergic and dopaminergic neuron differentiation by brain-derived neurotrophic factor but not neurotrophin 3. Proc Natl Acad Sci USA 88:961-965.
13. Korhonen L, Hamnér S, Olsson PA, Lindholm D (1997): Bcl-2 regulates the levels of the cysteine proteases ICH and CPP32/ Yama in human neuronal precursor cells. Eur J Neurosci 9:2489-2496.
14. Koves K, Arimura A, Gores TG, Somogyvari-Vigh A (1991): Comparative distribution of immunoreactive pituitary adenylate cyclase activating polypeptide and vasoactive intestinal polypeptide in rat forebrain. Neuroendocrinology 54:159-169.
15. Krieglstein K, Sutter-Crazzolara C, Fisher WH, Unsicker K (1995): TGF-β superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity. EMBO J 14:736-742.
16. Lenard Th, Unsicker K, Suter-Crazzolara C (1997): FGF-2 protection of hippocamnpal neurons from excitotoxic cell death is partially mediated by GDNF. Abstract 248.10, Society Neuroscience 27th Meeting, New Orleans 23:620.
17. Lin LF, Doherty DH, Lile JD, Bektesh S, Collins F (1993): GDNF: A glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science 260:1130-1132.
18. Lindholm D, Skoglösa Y, Takei N (1998): Developmental regulation of PACAP and its receptor 1 in rat brain: Function of PACAP as a neurotrophic factor. Ann NY Acad Sci (in press).
19. Lioudyno M, Skoglösa Y, Takei N, Lindholm D (1998): Pituitary adenylate cyclase activating polypeptide (PACAP) protects dorsal root ganglion neurons from death and induces calcitonin gene-related peptide (CGRP) immunoreactivity in vitro. J Neurosci Res 51:243-256.
20. Masuo Y, Ohtaki T, Masuda Y, Tsuda M, Fujino M (1992): Binding sites for pituitary adenylate cyclase activating polypeptide (PACAP): Comparison with vasoactive intestinal polypeptide (VIP) binding site localization in rat brain sections. Brain Res 575:113-123.
21. Miyata A, Arimura A, Dahl RR, Minamiro N, Uehara A, Jiang L, Culler MD, Coy DH (1989): Isolation of a novel 38 residue hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 164:567-574.
22. Miyata A , Jiang L, Dahl R, Kitada C, Kubo K, Fujino M, Minamino N, Arimura A (1990): Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38). Biochem Biophys Res Commun 170:643-648.
23. Morio H, Tatsuno I, Hirai A, Tamura Y, Saito Y (1996): Pituitary adenylate cyclase-activating polypeptide protects rat-cultured cortical neurons from glutamate-induced cytotoxicity. Brain Res 741:82-88.
24. Ogi K, Kimura C, Onda H, Arimura A, Fujino M (1990): Molecular cloning and characterization of cDNA for the precursor of rat pituitary adenylate cyclase activating polypeptide (PACAP). Biochem Biophys Res Commun 173: 1271-1279.
25. Pei G, Ebendal T(1996): Specific lesion in the extrapyramidal system of the rat induced by 3-nitropropionic acid (3-NPA). Exp Neurol 132:105-115.
26. Pietz K, Odin P, Funa K, Lindvall O (1996): Protective effect of platelet-derived growth factor against 6-hydroxydopamine-induced lesion of rat dopaminergic neurons in culture. Neurosci Lett 204:101-104.
27. Pincus DW, DiCicco-Bloom E, Black IB (1990): Vasoactive-intestinal peptide regulates mitosis, differentiation and survival of cultured sympathetic neuroblasts. Nature 343:564-567.
28. Skoglösa Y, Lewén A, Hillered L, Lindholm D (1997); Pituitary adenylate cyclase activating polypeptide(PACAP) expression in developing rat brain and posttraumatic upregulation in conjunction with BDNF. Abstract 673.3, Society Neuroscience 27th Meeting, New Orleans 23:1711.
29. Spengler D, Waeber C, Pantaloni C, Holsboer F, Bockaert J, Seeburg PH, Journot L (1993): Differential signal transduction by five splice variants of the PACAP receptor. Nature 365:170-175.
30. 2+ ionophore-induced apoptosis on cultured embryonic rat cortical neurons. Brain Res 652:65-70.
31. Takei N, Sasaoka K, Higuchi H, Endo Y, Hatanaka H (1996): BDNF increases the expression of neuropeptide Y mRNA and promotes differentiation/ maturation of neuropeptide Y-positive cultured cortical neurons from embryonic and postnatal rats. Mol Brain Res 37:283-289.
32. Tatsuno I, Morio H, Tanaka T, Uchida D, Hirai A, Tamura Y, Saito Y (1996): Pituitary adenylate cyclase-activating polypeptide (PACAP) stimulates proliferation and production of interleukin-6(IL-6), but not nerve growth factor (NGF) in cultured astro-cytes. Ann NY Acad Sci 805:482-488.
33. Tatsuno I, Yada T, Vigh S, Hidaka H, Arimura A (1992): Pituitary adenylate cyclase activating polypeptide and vasoactive intestinal peptide increase cytosolic free calcium concentration in cultured rat hippocampal neurons Endocrinology 131:73-81.
34. Uchida D, Arimura A, Somogyvari-Vigh A, Shioda S, Banks WA (1996): Prevention of ischemia-induced death of hippocampal neurons by pituitary adenylate cyclase activating polypeptide. Brain Res 736:280-286.
35. Villalba M, Bockaert J, Journot L (1997): Pituitary adenylate cyclase-activating polypeptide (PACAP-38) protects cerebellar garnule neurons from apoptosis by activating the mitogen-activated protein kinase (MAP kinase) pathway. J Neurosci 17:83-90.
36. Worby CA, Vega QC, Zhao Y, Chao HHJ, Seasholtz A F, Dixon JE (1996): Glial cell line-derived neurotrophic factor signals through the RET receptor and activates mitogen-activated protein kinase. J Biol Chem 271:23619-23622.